Home » Topics » Articles » Insight

Insight
RSS

Companies Continue To Refine Approaches To Antisense

June 14, 1999

Clinical Trials Update: May 1999

June 14, 1999

Public Financing Of Biotechnology: May 1999

June 7, 1999

Money Raised By Biotech In 1999: January May

June 7, 1999

Financing Outlook Brighter; Small-Caps Catch Up Slowly

June 7, 1999

Other Financings Of Public Biotechnology Companies: May 1999

June 7, 1999

Market Capitalization Of Selected Canadian Biotechnology Firms

May 31, 1999

Canada's Biotech Sector Marches Toward Maturity

May 31, 1999

Status Of Selected Products In Development At Canadian Biotechnology Firms

May 31, 1999

FDA Takes Steps To Speed Drug Development Process

May 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...